STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,000 | -43.8% | 4,632 | +56.5% | 0.00% | – |
Q2 2023 | $32,000 | +190.9% | 2,959 | +120.5% | 0.00% | – |
Q1 2023 | $11,000 | -76.1% | 1,342 | -73.3% | 0.00% | – |
Q4 2022 | $46,000 | +820.0% | 5,021 | +1318.4% | 0.00% | – |
Q3 2022 | $5,000 | +66.7% | 354 | +71.0% | 0.00% | – |
Q2 2022 | $3,000 | -88.9% | 207 | -83.5% | 0.00% | – |
Q1 2022 | $27,000 | -72.2% | 1,253 | -69.0% | 0.00% | – |
Q4 2021 | $97,000 | +136.6% | 4,048 | +153.3% | 0.00% | – |
Q3 2021 | $41,000 | -6.8% | 1,598 | +22.3% | 0.00% | – |
Q2 2021 | $44,000 | -13.7% | 1,307 | +0.2% | 0.00% | – |
Q1 2021 | $51,000 | +920.0% | 1,304 | +1593.5% | 0.00% | – |
Q4 2020 | $5,000 | +400.0% | 77 | +87.8% | 0.00% | – |
Q2 2020 | $1,000 | -50.0% | 41 | -53.9% | 0.00% | – |
Q1 2020 | $2,000 | -91.7% | 89 | -89.5% | 0.00% | – |
Q4 2019 | $24,000 | – | 848 | +3754.5% | 0.00% | – |
Q3 2019 | $0 | – | 22 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skorpios Trust | 14,443,681 | $56,908,103 | 99.78% |
Lynx1 Capital Management LP | 1,710,154 | $6,738,007 | 4.46% |
COWEN AND COMPANY, LLC | 3,721,659 | $14,663,336 | 1.03% |
Redmile Group, LLC | 3,872,696 | $15,258,422 | 0.73% |
RTW INVESTMENTS, LP | 4,390,558 | $17,298,799 | 0.36% |
Birchview Capital, LP | 85,000 | $334,900 | 0.28% |
Cormorant Asset Management, LP | 1,087,807 | $4,285,960 | 0.25% |
Granahan Investment Management | 851,201 | $3,353,732 | 0.12% |
GSA CAPITAL PARTNERS LLP | 348,069 | $1,371 | 0.12% |
Simplify Asset Management Inc. | 102,985 | $405,761 | 0.05% |